A3P Biomedical
Linnea Zillén has extensive work experience in the biomedical and life science industry. Starting in 2015, they worked as a Laboratory Assistant at Unilabs Sverige for two years. In 2017, they took on the role of Event Manager at SIV - Uppsalas kvinnliga ingenjörsnätverk until 2018.
In 2018, Linnea interned at Cytiva as a Research Intern and later as a Summer Engineering Intern. In 2019, they became a Master Thesis Student at Cytiva. During the same year, they also joined Olink Proteomics as a Development Engineer.
From 2020 to 2022, Linnea worked at Thermo Fisher Scientific as a Test/Verification Engineer. In 2019, they became a Life Science Consultant and later a Team Leader Process Assurance at Sigma Industry.
Their current role is as a Senior Laboratory Engineer at A3P Biomedical, a position they have held since September 2022.
Linnea Zillén studied at Uppsala University from 2013 to 2019, specializing in Molecular Biotechnology to obtain a Bachelor's degree in Civil Engineering.
This person is not in any offices
A3P Biomedical
1 followers
A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietaryalgorithm for the purpose of detecting aggressive prostate cancer at an early stage.